Hot Topics: Pharmaceuticals
by Berklee Robins, MD, MA & Ashley Sweet, MD, MBE
Vaccines are approved when it is clear that the benefits to the individual and society outweigh the potential risks and side effects of vaccination.…Full Article
by Dorit Reiss, PhD LLB, Art Caplan, PhD, and Working Group on Vaccine Ethics and Policy
The question whether the FDA will give an Emergency Use Authorization (EUA) to a COVID-19 vaccine is currently being widely discussed. The…Full Article
The Working Group on Compassionate Use and Preapproval Access (CUPA), a project of the NYU Grossman School of Medicine Division of Medical Ethics
The undersigned are members of a multidisciplinary group comprising bioethicists, clinicians, patient advocates, and representatives from industry and law who for the past seven years have been studying the ethical issues surrounding access to medical products before they have received regulatory approval.…Full Article
by Kiarash Aramesh M.D., Ph.D.
The COVID-19 pandemic has been accompanied by a surge of pseudoscientific claims, sometimes made or supported by political powers.…Full Article
by Keisha Ray, Ph.D.
I take the drug hydroxychloroquine, brand name Plaquenil, for an autoimmune disease. Hydroxychloroquine was once used to treat malaria and is now commonly used to treat a range of inflammatory disorders like lupus and rheumatoid arthritis.…Full Article
by Craig Klugman, Ph.D.
On March 31, the U.S. Department of Justice put in an order for $60,000 worth of hydroxychloroquine, a drug that Trump has been pushing as a treatment for COVID-19 (to clarify, it is unproven and has never worked on any other coronavirus).…Full Article
by Craig Klugman, Ph.D.
Dale is a 45-year-old woman who lives in Southern California. She has been a patient of Kaiser- Permanente to treat her chronic illness, systemic lupus erythematosus (SLE).…Full Article
by Amy C. Reese, MBe, PharmD
This country is in the midst of a health crisis. These past few weeks have reminded me of the ingrained duty that each healthcare professional has to patients.…Full Article
by Keisha Ray, Ph.D.
Like others in our WebMd culture I often go to the internet to research my symptoms, looking for possible solutions.…Full Article
Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization
The Limits of Individualism: Potential Societal Harms from the EAP for Convalescent Plasma
Attitudes Toward Cognitive Enhancement: The Role of Metaphor and Context
To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials
Undisclosed conflicts of interest among biomedical textbook authors
Ethical Guidance for Selecting Clinical Trials to Receive Limited Space in an Immunotherapy Production Facility
The Ethics of Advertising for Health Care Services
Recent news offers compelling evidence that an effective vaccine for #COVID19 is on its way. Although this news provides optimism, many questions are considered. Who gets it first? Could it help quell the pandemic? Questions follow this exciting news.Full Article
More and more microbes are becoming resistant to antimicrobial drugs, yet why are fewer antibiotics entering the market? For some, there is a lack of financial incentive to develop antibiotics and firms drop out in pursuit of more profitable drug lines.Full Article
Pain policy is not drug policy. If we want to improve the lives of people in pain and compress the terrible inequalities in its diagnosis and treatment, we have to tailor policy to the root causes driving our problems in treating pain humanely and equitably.Full Article
The Covid-19 pandemic threatens to harm efforts to reduce drug overdose deaths in two ways: mundanely—as with practically every other issue in the world right now—by simply overshadowing it; but worse, by exacerbating it.Full Article
Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus treatment.Full Article
In an bid to help speed up the development of potential treatment options and a vaccine for COVID-19, the National Institutes of Health on Friday announced a new public-private research partnership.Full Article
During public heath emergencies like the Covid-19 pandemic, when no known preventive or effective treatment exists, researchers understandably want to start conducting studies with humans as soon as possible to find a vaccine and therapeutic treatments that are safe and effective. Yet in the rush to find a Covid-19 vaccine and one or more drugs to treat the deadly disease, concerns are being raised that ethical standards for conducting human clinical trials, and the evidentiary standards for determining whether interventions are safe and effective, might be loosened.Full Article
As the United States was succumbing to an epidemic of addiction, the Johnson & Johnson family of companies became the leading maker of narcotics for popular opioid pills, a dominance achieved through decades of innovation, navigation of U.S. drug policy, and the cultivation of poppies in this remote haven on the other side of the world.Full Article
In rural Carter County, Tenn., health officials have embraced a strategy for stemming addiction: Teaching children as young as 6 how to reverse an overdose.Full Article
In October 2019, Dr. Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, testified before Congress that the United States “has become a world leader in drug discovery and development, but is no longer in the forefront of drug manufacturing.” The use of foreign-sourced materials “creates vulnerabilities in the U.S. supply chain,” Woodcock concluded.Full Article